Advertisement
Singapore markets closed
  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Bitcoin USD

    63,812.52
    -2,763.09 (-4.15%)
     
  • CMC Crypto 200

    1,355.01
    -27.56 (-1.99%)
     
  • FTSE 100

    8,091.40
    +51.02 (+0.63%)
     
  • Gold

    2,340.60
    +2.20 (+0.09%)
     
  • Crude Oil

    82.99
    +0.18 (+0.22%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     
  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Antibody Services Market Size to Reach USD 3.30 Billion in 2028 | Rising Approval Rate of Therapeutic Antibodies By Government Bodies and Surge in Demand For Protein Therapeutics Are Factors Boosting Industry Growth, says Emergen Research

Key players operating in the Antibody Services market are GE Healthcare, Thermo Fisher Scientific, Inc., Sartorius AG, Merck KGaA, Pall Corporation, Sigma-Aldrich Corporation, Eppendorf AG, Cellab GmbH, INTEGRA Biosciences AG, and FiberCell Systems Inc.

Vancouver, British Columbia, April 22, 2021 (GLOBE NEWSWIRE) -- The global antibody services market size is expected to reach USD 3.30 Billion in 2028 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research. Rising approval rate of therapeutic antibodies by government bodies, rising investment in biotechnology and pharmaceutical research, and surge in demand for protein therapeutics are some major factors boosting market revenue growth. Antibodies are immunoglobulin glycoproteins generated by plasma cells in reaction to foreign antigenic molecules.

The basic function of antibodies is to keep hold of specifically to these foreign antigens to impair them from destruction by the immune system, thereby safeguarding the host from any kind of infection. Antibody service includes various types and stages of antibody production, beginning from peptide designing, synthesis, and pairing of carrier protein with animal immunization, titer analysis, and antibody purification. Antibody development process begins with injection of antigen into the body of a laboratory animal, enabling their immune system to create a higher number of antibodies.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/632

ADVERTISEMENT

Most commonly utilized antibodies are IgG and IgM class antibodies. Antibodies are usually used in diagnostics applications such as pregnancy tests and detection of bacteria and different kinds of viruses in blood.

Some Key Findings From the Report:

  • Key players operating in the market are GE Healthcare, Thermo Fisher Scientific, Inc., Sartorius AG, Merck KGaA, Pall Corporation, Sigma-Aldrich Corporation, Eppendorf AG, Cellab GmbH, INTEGRA Biosciences AG, and FiberCell Systems Inc.

  • In January 2019, GenScript launched a new purification system, AmMag SA. This system simplified the process of protein and antibody purification and reduces processing time.

  • Monoclonal segment is expected to register a faster revenue CAGR as compared to other application segments throughout the forecast period. Commercialization of a large number of antibody-based products and growing investment in monoclonal antibody research are some key factors driving revenue growth of this segment.

  • North America accounted for a 30.1% revenue share in the global market in 2020. Robust presence of biotech and pharmaceutical companies, rapid development in healthcare and research infrastructure, and constant focus on drug discovery services are major factors driving revenue growth of the market in this region.

Check Our Prices@ https://www.emergenresearch.com/select-license/632

For the purpose of this report, Emergen Research has segmented the global antibody services market based on service, type, end-use, and region:

  • Service Outlook (Revenue, USD Billion; 2018–2028)

  • Antibody Development

  • Antibody Production & Purification

  • Antibody Fragmentation & Labeling

  • Type Outlook (Revenue, USD Billion; 2018–2028)

    • Monoclonal

    • Polyclonal

  • End-Use Outlook (Revenue, USD Billion; 2018–2028)

    • BioScience Companies

    • BioScience Research Institutions

    • Hospitals

    • Other

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/antibody-services-market

  • Regional Outlook (Revenue: USD Billion; 2018–2028)

    • North America

      1. U.S.

      2. Canada

      3. Mexico

    • Europe

      1. Germany

      2. France

      3. U.K.

      4. BENELUX

      5. Italy

      6. Spain

      7. Switzerland

      8. Russia

      9. Rest of Europe

    • Asia Pacific

      1. China

      2. Japan

      3. South Korea

      4. India

      5. Rest of APAC

    • Latin America

      1. Brazil

      2. Rest of LATAM

    • Middle East & Africa

      1. Saudi Arabia

      2. UAE

      3. South Africa

      4. Turkey

      5. Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-antibody-services-market